🇺🇸 FDA
Pipeline program

A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus

J1I-MC-GZQG

Phase 1 other active

Quick answer

A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus for Diabetes Mellitus is a Phase 1 program (other) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).

Program details

Company
Eli Lilly Co.
Indication
Diabetes Mellitus
Phase
Phase 1
Modality
other
Status
active

Clinical trials